Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Why EvoLV Stands Out Among Leading Biotech Consultants in California

Feb 06, 2025

Introduction to EvoLV's Pioneering Work

EvoLV is a prominent name in the biotech consulting industry, especially in California, a state known for its innovation and scientific advancement. As the biotech landscape continues to evolve, EvoLV has positioned itself as a leader by offering cutting-edge solutions and strategic guidance. This post explores why EvoLV stands out among its peers, detailing its unique approach and the value it brings to its clients.

biotech lab

Comprehensive Expertise Across Biotech Sectors

One of the primary reasons EvoLV excels is its broad expertise across various biotech sectors. From pharmaceuticals and medical devices to diagnostics and bioinformatics, EvoLV's team possesses diverse knowledge and experience. This allows them to offer customized solutions tailored to the specific needs of each client, ensuring that every project is handled with precision and expertise.

Moreover, EvoLV's consultants have a deep understanding of regulatory environments, which is crucial in navigating the complex biotech landscape. Their insights help clients streamline their processes, ensuring compliance while optimizing operational efficiency.

Focus on Innovation and Cutting-Edge Technology

Innovation is at the heart of EvoLV's consulting practice. By staying at the forefront of technological advancements, EvoLV can offer its clients the most current and effective strategies. The company invests heavily in research and development, ensuring that they are always informed about the latest trends and technologies shaping the biotech industry.

innovation technology

Client-Centric Approach

EvoLV's success is largely attributed to its client-centric approach. The company believes in building long-term relationships with its clients by understanding their unique challenges and goals. This personalized approach ensures that clients receive solutions that are not only effective but also aligned with their vision and objectives.

The firm also emphasizes clear communication and collaboration, fostering an environment where clients feel supported and empowered throughout their engagement with EvoLV.

Proven Track Record of Success

Over the years, EvoLV has built a strong reputation based on its proven track record of success. The firm has worked with numerous clients, helping them achieve significant milestones in their respective fields. Whether it's launching a new product or navigating complex regulatory hurdles, EvoLV's clients have consistently reached their goals with the firm's expert guidance.

success team

Commitment to Sustainability and Ethical Practices

In today's world, sustainability and ethical practices are more important than ever. EvoLV is committed to integrating these values into its consulting services. The firm prioritizes sustainable solutions that not only benefit their clients but also contribute positively to society and the environment.

By advocating for responsible innovation and ethical business practices, EvoLV sets itself apart as a consultant that cares about the broader impact of its work.

Conclusion: The EvoLV Advantage

EvoLV's ability to combine comprehensive expertise, a focus on innovation, a client-centric approach, a proven track record, and a commitment to sustainability makes it a standout choice among biotech consultants in California. For organizations looking to navigate the complex biotech landscape, EvoLV offers unparalleled support and guidance to ensure success in every endeavor.